Renal cell carcinoma (RCC) represents approximately 3% of all adult cancers and is more common in males. Systemic treatment for RCC has improved following the introduction of sunitinib. Bone metastases are present in up to 50% of RCC patients. We report a case of rapid improvement in metastatic bone lesions, recorded by nuclear bone scan, in a male patient receiving localized palliative radiotherapy in addition to systemic sunitinib and zoledronic acid. Concurrently, quality of life and performance status improved dramatically. Although we are unsure of the exact mechanism for such rapid improvement in metastatic bone lesions, the swiftness this improvement deserves reporting.

Download full-text PDF

Source
http://dx.doi.org/10.1089/jpm.2008.9846DOI Listing

Publication Analysis

Top Keywords

rapid improvement
12
renal cell
8
cell carcinoma
8
improvement metastatic
8
metastatic bone
8
bone lesions
8
improvement pain
4
pain functional
4
functional level
4
level patient
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!